A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease.

MLA

van der Stelt, Mario, et al. “A Role for Endocannabinoids in the Generation of Parkinsonism and Levodopa-Induced Dyskinesia in MPTP-Lesioned Non-Human Primate Models of Parkinson’s Disease.” FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 19, no. 9, July 2005, pp. 1140–42. EBSCOhost, https://doi.org/10.1096/fj.04-3010fje.

APA

van der Stelt, M., Fox, S. H., Hill, M., Crossman, A. R., Petrosino, S., Di Marzo, V., & Brotchie, J. M. (2005). A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson’s disease. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 19(9), 1140–1142. https://doi.org/10.1096/fj.04-3010fje

Chicago

van der Stelt, Mario, Susan H Fox, Michael Hill, Alan R Crossman, Stefania Petrosino, Vincenzo Di Marzo, and Jonathan M Brotchie. 2005. “A Role for Endocannabinoids in the Generation of Parkinsonism and Levodopa-Induced Dyskinesia in MPTP-Lesioned Non-Human Primate Models of Parkinson’s Disease.” FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 19 (9): 1140–42. doi:10.1096/fj.04-3010fje.